Stem cells take on Parkinson's: first safety trial begins
NCT ID NCT07232147
First seen Nov 18, 2025 · Last updated May 21, 2026 · Updated 20 times
Summary
This early-stage study tests whether a single treatment with human umbilical cord stem cells is safe and tolerable for people with Parkinson's disease. About 20 adults aged 18 to 75 will receive either stem cells or a placebo, and researchers will monitor side effects and any changes in movement symptoms. The goal is to gather initial safety data, not to cure the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MOVEMENT DISORDERS are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.